Tenecteplase received FDA approval in 2025 for acute ischemic stroke. It can be given as a single bolus and is considered noninferior to alteplase in benefit and safety.
Key points
FDA approved tenecteplase for acute ischemic stroke in 2025.
Tenecteplase dosing uses a tiered system approved by the FDA.
Sources
- Original post
- nej.md - Linked in the post
Foodome project uses AI to catalog food molecules
Foodome uses AI to identify and catalog molecules in everyday foods, creating a resource for exploring their effects on human health and potential medical applications. The initiative aims to make invisible food chemistry visible.
Key points
Project: Foodome uses AI to identify food molecules
Goal: Create a resource to explore health effects and medical applications
Sources
Science Immunology November 2026 issue live
Science Immunology November 2026 issue is live and the cover shows immune cells being modified directly within the body. It includes a new Review on in vivo immunoengineering.
Key points
Cover depicts immune cells being modified directly within the body.
New Review on in vivo immunoengineering is featured.
Sources
- Original post
- scim.ag - Linked in the post
